EA199800678A1 - Способ ингибирования мышечно-апоневротических фиброматозов (десмоидных опухолей) - Google Patents
Способ ингибирования мышечно-апоневротических фиброматозов (десмоидных опухолей)Info
- Publication number
- EA199800678A1 EA199800678A1 EA199800678A EA199800678A EA199800678A1 EA 199800678 A1 EA199800678 A1 EA 199800678A1 EA 199800678 A EA199800678 A EA 199800678A EA 199800678 A EA199800678 A EA 199800678A EA 199800678 A1 EA199800678 A1 EA 199800678A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- fibromatosis
- demoid
- aponurrotic
- tumors
- inhibiting muscular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1077396P | 1996-01-29 | 1996-01-29 | |
| GBGB9603148.9A GB9603148D0 (en) | 1996-02-15 | 1996-02-15 | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| PCT/US1997/002287 WO1997026878A1 (en) | 1996-01-29 | 1997-01-27 | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA199800678A1 true EA199800678A1 (ru) | 1999-02-25 |
Family
ID=26308707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA199800678A EA199800678A1 (ru) | 1996-01-29 | 1997-01-27 | Способ ингибирования мышечно-апоневротических фиброматозов (десмоидных опухолей) |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0907361A4 (no) |
| JP (1) | JP2000503995A (no) |
| KR (1) | KR19990082055A (no) |
| CN (1) | CN1209746A (no) |
| AU (1) | AU707675B2 (no) |
| CZ (1) | CZ235398A3 (no) |
| EA (1) | EA199800678A1 (no) |
| IL (1) | IL125523A0 (no) |
| NO (1) | NO983452L (no) |
| PL (1) | PL328127A1 (no) |
| WO (1) | WO1997026878A1 (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2135195C1 (ru) * | 1998-12-17 | 1999-08-27 | Овсюк Валерий Григорьевич | Способ получения материала, содержащего клетки предстательной железы, материал, содержащий клетки предстательной железы, и способы лечения фиброматоза матки, хронического простатита и нарушений мужской половой функции методом трансплантации |
| AU781168B2 (en) * | 2001-01-26 | 2005-05-12 | Pfizer Products Inc. | Method of treating certain cancers using an estrogen agonist/antagonist |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
| US5552162A (en) * | 1993-02-09 | 1996-09-03 | Arch Development Corporation | Method for improvement of scar size and appearance |
| NO943874L (no) * | 1993-10-15 | 1995-04-18 | Lilly Co Eli | Behandling av resistant neoplasma |
| US5457116A (en) * | 1993-10-15 | 1995-10-10 | Eli Lilly And Company | Methods of inhibiting uterine fibrosis |
| US5574047A (en) * | 1993-12-21 | 1996-11-12 | Eli Lilly And Company | Methods of inhibiting imperfect tissue repair |
-
1997
- 1997-01-27 AU AU21240/97A patent/AU707675B2/en not_active Ceased
- 1997-01-27 IL IL12552397A patent/IL125523A0/xx unknown
- 1997-01-27 EA EA199800678A patent/EA199800678A1/ru unknown
- 1997-01-27 WO PCT/US1997/002287 patent/WO1997026878A1/en not_active Application Discontinuation
- 1997-01-27 KR KR1019980705776A patent/KR19990082055A/ko not_active Application Discontinuation
- 1997-01-27 EP EP97906588A patent/EP0907361A4/en not_active Withdrawn
- 1997-01-27 CN CN97191916A patent/CN1209746A/zh active Pending
- 1997-01-27 CZ CZ982353A patent/CZ235398A3/cs unknown
- 1997-01-27 JP JP9527133A patent/JP2000503995A/ja active Pending
- 1997-01-27 PL PL97328127A patent/PL328127A1/xx unknown
-
1998
- 1998-07-27 NO NO983452A patent/NO983452L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU707675B2 (en) | 1999-07-15 |
| AU2124097A (en) | 1997-08-20 |
| CZ235398A3 (cs) | 1999-02-17 |
| JP2000503995A (ja) | 2000-04-04 |
| PL328127A1 (en) | 1999-01-18 |
| KR19990082055A (ko) | 1999-11-15 |
| NO983452D0 (no) | 1998-07-27 |
| WO1997026878A1 (en) | 1997-07-31 |
| EP0907361A4 (en) | 2002-05-02 |
| EP0907361A1 (en) | 1999-04-14 |
| IL125523A0 (en) | 1999-03-12 |
| NO983452L (no) | 1998-07-27 |
| CN1209746A (zh) | 1999-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950010888A (ko) | 평활근세포 증식 및 재발협착증을 억제하는 방법 | |
| RU97114956A (ru) | Способ ингибирования межклеточной адгезии и способ ингибирования воспалительного процесса | |
| MY132056A (en) | Methods of inhibiting physiological conditions associated with an excess of neuropeptide y. | |
| DE69430465D1 (de) | Hemmung uteriner Fibrose | |
| MX9701325A (es) | Metodos para inhibir la mucositis ulcerativa. | |
| EA199700450A1 (ru) | Способы подавления миграции сосудистых гладкомышечных клеток | |
| MX9701360A (es) | Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion. | |
| DE69412049D1 (de) | Hemmung von dysfunctionalen Uterusblutungen | |
| DK0652004T3 (da) | Fremgangsmåder til behandling af resistente neoplasmer | |
| RU98113525A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования тромботического расстройства, для увеличения активации протеина с | |
| DK0652002T3 (da) | Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning | |
| EA199800015A1 (ru) | Способ ингибирования меланомы | |
| ATE207748T1 (de) | Hemmung einer fehlentwicklung der ovarien, verspüteter pubertät oder sexuellem infantilismus | |
| EA199800019A1 (ru) | Способ повышения плотности кальциевых каналов | |
| KR950016734A (ko) | 성적 조숙증의 억제방법 | |
| EA199800366A1 (ru) | Способы ингибирования ингибитора 1 активатора плазминогена | |
| EA199700136A1 (ru) | Способы ингибирования экзогенных эстрогенов | |
| EA199800678A1 (ru) | Способ ингибирования мышечно-апоневротических фиброматозов (десмоидных опухолей) | |
| EA200000243A1 (ru) | Способы снижения количества тромбоцитов | |
| EA199700200A1 (ru) | Способы ингибирования рака яичника | |
| EA199800676A1 (ru) | Способы повышения компетенции сфинктера | |
| EA199800677A1 (ru) | Способ ингибирования опухоли толстой кишки | |
| MX9701327A (es) | Metodos para inhibir el cancer endometrial. | |
| MX9702148A (es) | Metodos para inhibir la mitosis endometrial. | |
| ATE200623T1 (de) | Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der primären endometriumhyperplasie |